Cervical cancer vaccine approved in Canada: Knowledge Driven Revolution

Health Canada has approved a vaccine that protects against the human papilloma virus, or HPV, which is responsible for most cases of cervical cancer, the vaccine's manufacturer announced Tuesday.

HPV is said to infect half of all sexually active women between ages 18 and 22 in North America. In most women, the virus clears up on its own, but if the infection persists, it can lead to cervical cancer.

"Until now, we have only been able to react to the effects of HPV in women," said Dr. Guylaine Lefebvre, president-elect of the Society of Obstetricians and Gynaecologists of Canada. "Now we are talking about preventing most of the serious diseases caused by HPV."

Read the full article here

Article Continued...

This year in Canada, nearly 1,400 new cases of cervical cancer are expected and approximately 390 women will die from the disease.

Montreal-based Merck Frosst Canada Ltd. said its vaccine, called Gardasil, is approved for females between nine and 26 years of age to prevent:

* Cervical cancer.
* Vulvar cancer.
* Vaginal cancer.
* Precancerous lesions.
* Genital warts caused by HPV.

The vaccine will be available in Canada by the end of August through Canadian doctors and pharmacists.

U.S. regulators approved the vaccine in June, at a cost of $360 US for a course of three treatments.

Ideally, the vaccine would be given to children before they become sexually active and face exposure to the virus.

After the U.S. announcement, Canada's advisory committee on immunization started discussing whether to employ Gardasil in school-based vaccine programs.

"The issues now are not medicine and science," said Dr. Simon Sutcliffe, who heads the Canadian Strategy for Cancer Control. "They are pracitical, logistical and ethical issues about population vaccination."

Since the vaccine doesn't prevent infection from all strains of HPV, women would still need to get a Pap test to screen for the virus.

It will be up to the provinces to decide who should receive the vaccine, how to deliver it, and how to pay for it.

Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking the "Expand/Collapse" button below.


HOME Articles by KDR V for Vendetta - R for Reality Canadian Bird Flu Pandemic Looming ? Shill of the Week: Stephan Harper Aspartame: The Sweetest Killer Chicken Little Terrorist of the Week: Creating Fake Terrorists Shill of the Week: Paul Martin The Number 1 Reason YOU became a Slave	Cervical cancer vaccine approved in Canada CBC News July 21, 2006 Health Canada has approved a vaccine that protects against the human papilloma virus, or HPV, which is responsible for most cases of cervical cancer, the vaccine's manufacturer announced Tuesday. HPV is said to infect half of all sexually active women between ages 18 and 22 in North America. In most women, the virus clears up on its own, but if the infection persists, it can lead to cervical cancer. "Until now, we have only been able to react to the effects of HPV in women," said Dr. Guylaine Lefebvre, president-elect of the Society of Obstetricians and Gynaecologists of Canada. "Now we are talking about preventing most of the serious diseases caused by HPV." Read the full article here Article Continued... This year in Canada, nearly 1,400 new cases of cervical cancer are expected and approximately 390 women will die from the disease. Montreal-based Merck Frosst Canada Ltd. said its vaccine, called Gardasil, is approved for females between nine and 26 years of age to prevent: * Cervical cancer. * Vulvar cancer. * Vaginal cancer. * Precancerous lesions. * Genital warts caused by HPV. The vaccine will be available in Canada by the end of August through Canadian doctors and pharmacists. U.S. regulators approved the vaccine in June, at a cost of $360 US for a course of three treatments. Ideally, the vaccine would be given to children before they become sexually active and face exposure to the virus. After the U.S. announcement, Canada's advisory committee on immunization started discussing whether to employ Gardasil in school-based vaccine programs. "The issues now are not medicine and science," said Dr. Simon Sutcliffe, who heads the Canadian Strategy for Cancer Control. "They are pracitical, logistical and ethical issues about population vaccination." Since the vaccine doesn't prevent infection from all strains of HPV, women would still need to get a Pap test to screen for the virus. It will be up to the provinces to decide who should receive the vaccine, how to deliver it, and how to pay for it. Broken Link? If the link to the original article is broken or has been altered you can view the article by clicking the "Expand/Collapse" button below. About KDR \| \| Home \| \| Weekly Features Archive	Weekly Weekly Features Archive
		In Depth What Is Wrong With Canada? Recent 9-11 News Suppressed by the Media Aspartame: The Sweetest Killer The Number 1 Reason YOU became a Slave Knowledge Driven Look at Your Favourite Canadian Political Parties
		Archive May June July 2006 25 26 27 28 29 30 01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 01 02 03 04 05 Weekly Features 2006 2005 Read Today's Knowledge Driven News
		Counter
Copyright © 2005-6 KnowledgeDrivenRevolution.com

Articles by KDR

Cervical cancer vaccine approved in Canada

Weekly

In Depth

Archive